Insider Transactions in Q2 2023 at Enhabit, Inc. (EHAB)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2023
|
Tina L. Brown Stevenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+36.24%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Jeffrey Bolton Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+28.23%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
L Edward Shaw Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+19.73%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Leo I Higdon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+29.9%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Charles M Elson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+26.76%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Yvonne M Curl Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+29.53%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Erin Hoeflinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+30.9%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Stuart M Mcguigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+46.53%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Gregory S Rush Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+30.24%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Barry P. Schochet Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+46.53%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
Susan La Monica Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+26.19%
|
$139,722
$11.81 P/Share
|
|
Jun 28
2023
|
John E Jr D D S Maupin Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,702
+29.68%
|
$139,722
$11.81 P/Share
|
|
May 26
2023
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
2,000
+9.26%
|
$22,000
$11.61 P/Share
|
|
May 22
2023
|
L Edward Shaw Jr Director |
BUY
Open market or private purchase
|
Direct |
10,000
+20.41%
|
$110,000
$11.98 P/Share
|
|
May 18
2023
|
Erin Hoeflinger Director |
BUY
Open market or private purchase
|
Direct |
2,100
+11.8%
|
$23,100
$11.82 P/Share
|
|
May 18
2023
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
BUY
Open market or private purchase
|
Direct |
10,000
+18.41%
|
$110,000
$11.99 P/Share
|
|
May 17
2023
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
2,000
+10.21%
|
$22,000
$11.8 P/Share
|